NCT05165875

Splint Versus Steroid Randomized Trial

Splint Versus Steroid Injection for DeQuervain's Tenosynovitis: A Randomized Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: National University Hospital, Singapore · Academic / Other
• Sex: Female
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The primary aim is to compare the effectiveness of splinting versus steroid injection in improving the DASH scores in participants diagnosed with De Quervain's tenosynovitis over a period of 6 months.

Detailed description

The primary hypothesis is that steroid injection into the first dorsal compartment is more effective compared with splinting at 3 months. The secondary hypothesis is that steroid injection yields better clinical outcomes compared with splinting at 1 month, 3 months and 6 months.

Conditions

• De Quervain Syndrome

Interventions

Type	Name	Description
DRUG	Hydrocortisone-Lidocaine	Intervention will be done on the same day based on the randomization. For the steroid injection group, a 1ml injection of a mixture of 0.5ml triamcinolone acetonide (50mg/5ml) and 0.5ml 1% lignoacaine is given intra-thecally into the first extensor compartment. For both groups, routine analgesia is not prescribed but the use is not restricted to the participants.
OTHER	Splint	Intervention will be done on the same day based on the randomization. For the splint group, a long thumb spica thermoplastic splint (wrist neutral, 30º CMCJ flexion, 30º thumb abduction, IPJ free) will be customized and intermittent active range of motion exercises will be taught for 4 weeks. Subsequently, the splint will be weaned and passive range of motion exercises taught. For both groups, routine analgesia is not prescribed but the use is not restricted to the participants.

Timeline

• Start date: 2022-06-01
• Primary completion: 2024-02-01
• Completion: 2024-02-01
• First posted: 2021-12-21
• Last updated: 2022-03-09